GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Holdings Raised by Lake Street Advisors Group LLC

Lake Street Advisors Group LLC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 2,837 shares of the company’s stock after purchasing an additional 288 shares during the quarter. Lake Street Advisors Group LLC’s holdings in GE HealthCare Technologies were worth $222,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of the business. Assenagon Asset Management S.A. lifted its stake in shares of GE HealthCare Technologies by 10.1% in the 3rd quarter. Assenagon Asset Management S.A. now owns 13,735 shares of the company’s stock worth $1,289,000 after acquiring an additional 1,256 shares during the period. Valmark Advisers Inc. purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $222,000. US Bancorp DE lifted its position in shares of GE HealthCare Technologies by 0.9% in the 3rd quarter. US Bancorp DE now owns 296,382 shares of the company’s stock valued at $27,815,000 after acquiring an additional 2,664 shares in the last quarter. Cigna Investments Inc. New lifted its position in shares of GE HealthCare Technologies by 4.4% in the 3rd quarter. Cigna Investments Inc. New now owns 4,558 shares of the company’s stock valued at $428,000 after acquiring an additional 193 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its position in shares of GE HealthCare Technologies by 10.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 4,520 shares of the company’s stock valued at $424,000 after acquiring an additional 443 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 2.3 %

Shares of GE HealthCare Technologies stock opened at $87.35 on Friday. The firm has a 50-day moving average of $86.17 and a 200-day moving average of $86.10. The stock has a market cap of $39.94 billion, a PE ratio of 20.17, a PEG ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on GEHC. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup upped their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Finally, Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.